Medical technology company RaySearch Laboratories AB (publ) (STO:RAY-B) announced on Friday the appointment of Nina Grönberg as the new chief financial officer, effective 27 January 2025.
With extensive experience in finance leadership roles at various international publicly listed companies, Nina most recently served as CFO at Team Olivia and held previous CFO positions at Duroc. Additionally, she has contributed to accounting, reporting, and business control at Ratos and Munters.
Nina Grönberg says: "RaySearch is an innovative company and a driving force in the fight against cancer. The finance function has an important role to play in this exciting phase of expansion that RaySearch is currently undergoing."
Relay Therapeutics wins FDA breakthrough status for zovegalisib in breast cancer treatment
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil
Lupin launches Dasatinib tablets in US market
WuXi Biologics enters into licence and research service agreement with Vertex Pharmaceuticals
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
AstraZeneca agrees obesity and type 2 diabetes collaboration with CSPC
Ascletis Pharma Inc reports topline results from Phase III open-label study of denifanstat
Innovative Molecules GmbH completes Phase 1 clinical development programme for adibelivir
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA